BSE filing, BSE: 543543. Summary written from the filing by ALFA Finder's alert engine.
B-Right Realestate Ltd: key numbers
- Share price
- ₹923.50
- Market cap
- ₹954.1 Cr
- Revenue (annual)
- ₹167.8 Cr
- Net profit (annual)
- ₹35.15 Cr
- P/E (TTM)
- 27.1×Sector 33.7×
- Promoter holding
- 73.15%+0.00% QoQ
- FII holding
- 1.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from B-Right Realestate Ltd
All →B-Right Realestate Board Meeting Date
B-Right Realestate will hold a board meeting on 31 October 2026 to consider its unaudited standalone and consolidated results for the half year ended September 30, 2026. This is a prior intimation under Regulation 29, and the agenda is proposed only.
B-Right Realestate Credit Rating
B-Right Realestate received a credit rating reaffirmation of IVR BBB- / Stable from Infomerics. The agency removed the rating from watch with negative implications.
B-Right Realestate Merger & Restructuring Worth ₹0.01 Cr
B-Right Realestate's subsidiary, B-Right Realestate Ventures LLP, incorporated a new entity, B-Right Bombay Highlines Township Private Limited, acquiring an 80% stake for Rs. 0.008 Crore.
- Value
- ₹0.01 Cr
B-Right Realestate Business Update
B-Right RealEstate reported Q2 FY27 operational highlights, including Pre-Sales of Rs. 54.94 Cr, collections of Rs. 68.64 Cr, and a total debt of Rs. 120 Cr.
B-Right Realestate Other Announcement
B-Right Realestate Limited filed its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the period ended September 30, 2026.
B-Right Realestate Business Update
B-Right Realestate won the Excellence in Urban Renewal award at GROHE Hurun India Real Estate Awards 2026. Q1 FY27 pre-sales reached ₹180.94 crore, up 128% YoY.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.